Viral Hepatitis
📧 Sign up to get email alerts when something new happens for Viral Hepatitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-03-23FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for EPIVIR (lamivudine) submitted by ViiV Healthcare Company, indicating changes to its labeling…
-
FDA approval · 2015-02-19FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for EPIVIR (lamivudine) submitted by ViiV Healthcare Company.
-
FDA approval · 2015-02-19FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for EPIVIR (lamivudine) submitted by ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: Study to Compare Booster Vaccination With Pediacel® to Infanrix® Hexa When Both Are Co-Administered With Prevenar® [Phase 3]
Phase 3 trial comparing booster vaccination with Pediacel versus Infanrix Hexa when co-administered with Prevenar in healthy infants has com…
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: A Pilot Study to Evaluate the Safety and Efficacy of Clevudine or Adefovir Patients With LC-B [Phase 3]
A completed Phase 3 pilot study evaluating the safety and efficacy of Clevudine or Adefovir in patients with LC-B.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-12-18FDA Approved: LAMIVUDINE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' original application for lamivudine as a generic product.
-
CLINICAL_TRIALS trial_result · 2014-11-07Clinical Trial Update: Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity [NA]
A completed clinical trial evaluated Acoustic Radiation Force Impulse Imaging (ARFI) as a noninvasive method to assess liver elasticity.
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent Patients [NA]
Completed clinical trial evaluating computer-based cognitive behavioral therapy to reduce risky behaviors in patients with opioid dependence…
-
EMA guidance · 2014-07-25World Hepatitis Day – European Medicines Agency uses regulatory tools to facilitate patient access to innovative medicines
EMA highlights use of regulatory tools to improve timely patient access to innovative medicines for hepatitis on World Hepatitis Day.
-
CLINICAL_TRIALS research · 2014-05-20Clinical Trial Update: Accuracy of RTE for Evaluating Hepatic Fibrosis in Chronic Hepatitis: a Prospective Multicenter Study
A prospective multicenter study evaluating the accuracy of Real-Time Elastography (RTE) for assessing hepatic fibrosis in chronic hepatitis …
-
CLINICAL_TRIALS trial_result · 2014-03-28Clinical Trial Update: Blood-borne Infection Screening in an Afghan Antenatal Population [NA]
A completed clinical trial evaluated blood-borne infection screening for Hepatitis B in an antenatal population in Afghanistan, with results…
-
CLINICAL_TRIALS research · 2014-03-03Clinical Trial Update: TO Compare the Triple Drug Therapy and Dual Therapy . [Phase 4]
A Phase 4 clinical trial update from Asan Medical Center comparing triple drug therapy to dual therapy for hepatitis; current status is UNKN…
-
FDA approval · 2013-12-04FDA Approved: KIT FOR THE PREPARTION OF TECHNETIUM TC99M SULFUR COLLOID — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for a kit used to prepare Technetium-99m sulfur colloid for nuclear medicine imaging.
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Hepatitis B Vaccine Clinical Trial [Phase 3]
Phase 3 clinical trial of a Hepatitis B vaccine has completed. The update provides no results.
-
EMA guidance · 2013-11-22European Medicines Agency advises on compassionate use of daclatasvir
The European Medicines Agency provides guidance on compassionate use of the antiviral daclatasvir, outlining conditions and considerations f…
-
CLINICAL_TRIALS research · 2013-11-11Clinical Trial Update: Usefulness of Multi-parametric, Quantitative MR Imaging for Staging of Hepatic Fibrosis in the Patients With Chronic Hepatitis
This clinical trial update assesses the usefulness of multi-parametric, quantitative MRI for staging hepatic fibrosis in patients with chron…
-
FDA approval · 2013-11-08FDA Approved: EMTRIVA — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for EMTRIVA (emtricitabine) submitted by Gilead Sciences.
-
EMA guidance · 2013-10-25European Medicines Agency advises on compassionate use of sofosbuvir
EMA provides guidance on compassionate use of sofosbuvir, outlining how it can be accessed in certain circumstances outside of approved indi…
-
EMA guidance · 2013-07-26World Hepatitis Day: 28 July 2013
Official EMA communication marking World Hepatitis Day (July 28, 2013) to raise awareness about hepatitis and the importance of prevention, …
-
CLINICAL_TRIALS trial_result · 2013-07-01Clinical Trial Update: Comparative Pharmacokinetics and Pharmacodynamics of Peginterferon BIP48 and 40kDa in Healthy Volunteers [Phase 1]
Phase 1 trial comparing pharmacokinetics and pharmacodynamics of two pegylated interferon formulations (BIP48 and a 40 kDa peginterferon) in…
-
CLINICAL_TRIALS research · 2013-06-04Clinical Trial Update: Evaluation of Role of Transient Elastography (Fibroscan) in Differentiating Patients of Acute Severe Viral Hepatitis and Acute on Chronic Liver Failure
This clinical trial evaluates whether transient elastography (Fibroscan) can differentiate between acute severe viral hepatitis and acute-on…
-
FDA approval · 2013-05-16FDA Approved: PEGASYS — Supplemental Application (pharmaand GmbH)
FDA approved a supplemental application for PEGASYS (peginterferon alfa-2a) submitted by pharmaand GmbH.
-
EMA withdrawal · 2013-05-06EMA Lapsed: Ribavirin BioPartners (ribavirin) — BioPartners GmbH
EMA status indicates ribavirin product by BioPartners GmbH has lapsed (withdrawn).
-
CLINICAL_TRIALS trial_result · 2013-04-22Clinical Trial Update: Genotype Based Personalized Prescription of Nevirapine [Phase 4]
A Phase 4 clinical trial evaluating genotype-based personalized prescribing of nevirapine has completed, examining nevirapine-induced rash a…
-
CLINICAL_TRIALS trial_result · 2013-04-18Clinical Trial Update: A Network & Dyad HIV Prevention Intervention for IDU's - 1 [Phase 2]
Phase 2 results posted for a network and dyad HIV prevention intervention targeting injection drug users; the study is completed and results…